| 000 | 01126 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515165509.0 | ||
| 264 | 0 | _c20090828 | |
| 008 | 200908s 0 0 eng d | ||
| 022 | _a1879-016X | ||
| 024 | 7 |
_a10.1016/j.pharmthera.2009.03.013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFassnacht, Martin | |
| 245 | 0 | 0 |
_aNew targets and therapeutic approaches for endocrine malignancies. _h[electronic resource] |
| 260 |
_bPharmacology & therapeutics _cJul 2009 |
||
| 300 |
_a117-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aEndocrine Gland Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 700 | 1 | _aKreissl, Michael C | |
| 700 | 1 | _aWeismann, Dirk | |
| 700 | 1 | _aAllolio, Bruno | |
| 773 | 0 |
_tPharmacology & therapeutics _gvol. 123 _gno. 1 _gp. 117-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pharmthera.2009.03.013 _zAvailable from publisher's website |
| 999 |
_c18806529 _d18806529 |
||